{"disease":{"id":"herpes-zoster-vaccine","name":"herpes zoster vaccine"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01165229","title":"Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14819,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02723773","title":"A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":7539,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06851832","title":"Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":960,"lead_sponsor_name":"Ab&B Bio-tech Co., Ltd.JS","has_results":false},{"nct_id":"NCT02045836","title":"Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":865,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02075515","title":"Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":651,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07400003","title":"Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":519,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT04516408","title":"Recombinant Zoster Vaccine in Stable SLE Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":464,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT01772160","title":"Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy","phase":"","overall_status":"COMPLETED","enrollment_count":395,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01798056","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05245838","title":"Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Dynavax Technologies Corporation","has_results":false},{"nct_id":"NCT05750017","title":"A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Beijing Luzhu Biotechnology Co., Ltd.","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}